Cover Page
Cover Page | May 18, 2020 |
Cover [Abstract] | |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Entity Central Index Key | 0001576263 |
Amendment Flag | false |
Document Type | 8-K |
Document Period End Date | May 18, 2020 |
Entity Registrant Name | Mirati Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-35921 |
Entity Tax Identification Number | 46-2693615 |
Entity Address, Address Line One | 9393 Towne Centre Drive, Suite 200 |
Entity Address, City or Town | San Diego |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92121 |
City Area Code | 858 |
Local Phone Number | 332-3410 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Document Fiscal Year Focus | 2020 |
Document Fiscal Period Focus | Q2 |
Trading Symbol | MRTX |
Security Exchange Name | NASDAQ |